DSM completes acquisition of PTG
Steve Hartig, President DSM Biomedical, commented: "We are excited that our acquisition of PTG has closed and look forward to moving forward with a combined effort. With PTG, DSM obtains a leading position in the field of biomedical polymers. This acquisition will enable us to grow a unique portfolio of materials-based technologies for the healthcare market. This will allow acceleration in our business growth and market presence."
Bob Ward, President and one of the founders of PTG: "We see the combination of PTG and DSM's biomedical activities as a huge step allowing us to better serve our customers in the medical device and pharmaceutical industries by bringing a much greater breadth of products, technology and services to bear."
The DSM Biomedical and PTG organization will be closely linked to best service the global market. To secure a smooth integration Bob Ward will stay on as President of DSM PTG.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.